Congressional leaders’ proposal to keep the Food and Drug Administration operating for the rest of fiscal year 2024 instructs the agency to find $7m within its budget to reallocate to implementing its expanded regulatory toolkit for cosmetics.
A budget agreement reached by House and Senate leaders and a conference committee, which they published with their bill, HR 4366, includes the FDA’s proposed spending for the Department of Agriculture and related agencies and also includes budgets funding the Transportation, Veterans Affairs, Energy,
The bill,